Abstract. The present study aimed to investigate the effect, and elucidate the potential mechanisms, of 9-hydroxypheophorbide α-based photodynamic therapy (9-HPbD-PDT) on apoptosis and necrosis induction, and migration suppression of laryngeal cancer AMC-HN-3 (HN-3) cells. Phototoxicity initiated by 9-HPbD-PDT on HN-3 cells was observed in a photosensitizer dose-dependent pattern. There was an initial increase of apoptotic cells coupled with gradual enhancement of reactive oxygen series (ROS) generation at lower doses of 9-HPbD. By contrast, at a higher dose of 9-HPbD, there was a clear increase of necrotic cells with a gradual decrease of ROS generation. Following PDT, an elevated percentage of apoptotic cells with shrinkage or condensing nuclei was observed using Hoechst 33342/propidium iodide double staining, and an upregulated expression of poly ADP-ribose polymerase was detected through western blotting. A disruption of the mitochondrial membrane potential was detected 2 h following PDT. Significant suppression of cell migration and downregulation of epidermal growth factor receptor (EGFR) expression were recorded following PDT. These results indicate that the distribution of photosensitizer leads to differences in the generation of ROS, which subsequently determines the type of cell death. Overall, mitochondrial activation under oxidative stress is important in the 9-HPbD-PDT-induced apoptosis of HN-3 cells. Migration suppression of HN-3 cells following PDT may be associated with the inhibited expression of EGFR, due to oxidative stress.
Introduction
As an emerging and promising cancer therapy, photodynamic therapy (PDT) activates and destroys photosensitizer-incubated tumor cells using wavelength-matched visible light irradiation. PDT initiates apoptotic and necrotic cell death in vivo and in vitro (1) ; however, the factors involved in the overall process and the contribution to either mechanism are not completely elucidated.
PDT has previously demonstrated novel effects in the treatment of oncologic diseases; however, the limitations of laser penetration into normal tissues and long-lasting cutaneous photosensitivity following irradiation are unavoidable, and may affect the applicability of PDT to malignant tumor therapy (2) . As a novel chlorophyll derived photosensitizer, 9-hydroxypheophorbide α (9-HPbD) has a relatively longer absorption wavelength (664 nm) and a shorter half-life in the body compared with other photosentisizers (3) . In addition, 9-HPbD exhibited an apoptosis-inducing effect and growth suppression in MCF-7 human breast cancer cells (3) . A previous study concerning combination treatment with 9-HPbD-PDT and carboplatin resulted in an enhanced photocytotoxicity and apoptosis induction in laryngeal AMC-HN-3 (HN-3) cancer cells (4) . Oxidative stress-directed cell death and migration suppression of HN-3 cells using 9-HPbD-PDT is additionally investigated in the present study.
The present study aimed to investigate the effect, and elucidate the potential mechanisms, of 9-HPbD-PDT on apoptosis and necrosis induction, as well as migration suppression, of HN-3 cells.
Materials and methods
Reagents and antibodies. All media and supplements for cell culture were supplied by Hyclone™ (GE Healthcare Life Sciences, Logan, UT, USA). Dimethyl sulfoxide (DMSO), Photosensitizer effect of 9-hydroxypheophorbide α on diode laser-irradiated laryngeal cancer cells: Oxidative stress-directed cell death and migration suppression Cell culture. The HN-3 cell line (5) was developed from a 63-year-male patient with previously untreated laryngeal squamous cell carcinoma, and was kindly provided by Asan Medical Center (Seoul, Korea). The cell line was cultured in RPMI-1640 medium supplemented with 10% fetal bovine serum, penicillin (50 units/ml) and streptomycin (50 µg/ml) at 37˚C in a 5% CO 2 and 95% air atmosphere in a humidified incubator.
PDT protocol. 9-HPbD (3) was kindly donated by Kumho Life and Environmental Science Laboratory (Kwangju, Korea). 9-HPbD was stored in ethanol (1.5 mg/ml) and aluminum foil at -20˚C. HN-3 cells at 90% confluence were incubated with 9-HPbD in the dark for 6 h at 37˚C. Subsequent to changing the culture medium, 9-HPbD-photosensitized cells were subsequently exposed to a 664 nm diode laser (Hi-Tech Optoelectronics, Co., Ltd., Beijing, China) at 2.0 J/cm 2 for 15 min. In order to assess the antioxidant effect, HN-3 cells were incubated simultaneously with either 5 mM GSH or 2.5 mM ascorbic acid and 0.59 µg/ml 9-HPbD. Subsequently, the incubated cells were irradiated by laser, according to the aforementioned conditions. Cell viability assay. A MTT assay was used to measure cell viability. The treated cells at 90% confluence were incubated with 50 µl MTT solution (2 mg/ml) for 2 h. The MTT solution was exchanged with 100 µl DMSO and the absorbance at 540 nm was measured following 20 sec of shaking. Cell viability was calculated according to the following equation: Cell viability (%) = (mean absorbance in treatment group / mean absorbance in control group) x 100.
Detection of reactive oxygen species (ROS) and 9-HPbD fluorescence. Generation of ROS was detected by H 2 DCFDA staining as previously described (6) . In brief, treated cells at 90% confluence were incubated with 2 µM H 2 DCFDA at 37˚C for 30 min, and then gently washed twice with Dulbecco's phosphate-buffered saline (DPBS). Images of green H 2 DCFDA were captured using an excitation light from a 488 nm argon laser, 560 nm dichroic mirror and 505-550 nm band pass barrier filter. 9-HPbD was excited with a 633 nm helium/neon laser. Band-pass emission filters of 530-600 and 420-480 nm were used to identify ROS green signal (channel 1) and 9-HPbD red fluorescence (channel 2). A 650 nm long pass emission filter was applied for 9-HPbD.
Hoechst 33342 and PI double staining. The treated cells at 90% confluence were stained with Hoechst 33342 for 30 min and PI for 10 min and observed using confocal microscopy, as previously described (4) . Hoechst 33342 is a fluorescent dye that specifically stains nucleic acid. Hoechst 33342-stained normal cells exhibit regular and round nuclei (blue), while the nuclei of apoptotic cells are crimpy or condensed (bright blue). However, PI penetrates the cytoplasmic membrane of oncotic cells (late apoptotic and necrotic cells) and stains the nuclei pink. Due to the intact cytoplasmic membrane, the nuclei of normal cells and early apoptotic cells are not stained by PI.
Measurement of mitochondrial membrane potential (MMP).
In brief, the treated cells at 60-70% confluence were stained with 1 µM rhodamine 123 for 30 min, and subsequently the cells were gently washed twice with DPBS. Images of green fluorescence from rhodamine 123 stained mitochondria were captured with confocal microscopy with an excitation wavelength of 488 nm, 560 nm dichroic mirror and 505-550 nm band pass barrier filter. MMP was further detected using flow cytometry (BD Biosciences, San Jose, CA, USA). Briefly, suspended cells were incubated with 1 µM rhodamine 123 for 30 min and monitored by the FL1-H channel. Data were analyzed using BD CellQuest™Pro software, version 2.0 (BD Biosciences). A minimum of 20,000 events were counted.
Wound healing assay. The HN-3 cells were cultured in 10 cm petri dishes until the monolayer was 80-90% confluent. Following PDT treatment, the cell monolayer was lesioned using a 1.2 mm cell scraper without damaging the dish surface. Images of the lesion areas were captured at 0 and 24 h following PDT. The photos were analyzed using Adobe Photoshop CS6 (Adobe Systems Inc., San Jose, CA, USA). The distance of cell migration was calculated by subtracting the distance between the lesion edges at 24 h from the distance measured at 0 h. The values were expressed in mm.
Western blotting analysis. Following treatment with PDT, the cells at 90% confluence were harvested and total proteins were extracted using RIPA buffer. Protein concentrations were determined with Bradford dye reagent. Equivalent amounts of protein (100 µg) were loaded onto 10% polyacrylamide gels, subjected to electrophoresis, and transferred to polyvinylidene difluoride membranes. Electrophoresis and blotting were performed using the PowerPac™ Basic Power Supply Electrophoresis System 200 (Bio-Rad Laboratories, Inc., Hercules, CA, USA). The membranes were blocked with 5% skimmed milk for 1 h, followed by incubation with the primary antibodies against PARP, EGFR and GAPDH overnight at 4˚C. Subsequently, the membranes were incubated with horseradish peroxidase-conjugated goat anti- 
Statistical analysis.
Results are expressed as the mean ± standard deviation. Significant differences were evaluated using one-way analysis of variance followed by least significant difference method. Statistical analyses were performed using SPSS 11.5 software (SPSS, Inc., Chicago, IL, USA). P<0.05 was considered to indicate a statistically significant difference.
Results
Photocytotoxic effect of 9-HPbD. The photocytotoxicity exhibited by 9-HPbD-PDT on HN-3 cells was validated by a MTT assay. With diode laser irradiation, the photocytotoxic effect of 9-HPbD on HN-3 cells exhibited a photosensitizer dose-dependent pattern. Neither PDT nor 9-HPbD alone was photocytotoxic to HN-3 cells. As shown in Fig. 1 , cell viability was significantly suppressed at 0.29 µg/ml 9-HPbD-PDT compared with control cells (P=0.021). At higher doses of 9-HPbD (≥0.59 µg/ml), cell viability was also significantly suppressed compared with control cells (P<0.01).
ROS generation, 9-HPbD fluorescence and cell death induction by 9-HPbD-PDT. As shown in Fig. 2A, 9 -HPbD fluorescence was increased with increasing doses of 9-HPbD. Intracellular formation of ROS was detected by the conversion of non-fluorescent H 2 DCFDA to fluorescent 2,7-dichlorofluorescein diacetate (DCFDA). As shown in Fig. 2A , DCFDA fluorescence increased between 0.29 and 1.17 µg/ml 9-HPbD-PDT. Subsequently, the intensity of DCFDA fluorescence broke down gradually between 1.17 and 4.69 µg/ml 9-HPbD-PDT 1 h following laser irradiation.
A total of 24 h following PDT, the cells exhibited blurred and shrinkable cellular contours. Apoptotic cells, marked with condensed/fragmented blue or pink nuclei, were observed in a dose-dependent manner following treatment with 0.29-1.17 µg/ml 9-HPbD-PDT. There was a gradual increase in necrotic cells, which exhibited pink intact nuclei, in cells treated with higher doses of 9-HPbD (1.17-4.69 µg/ml). The cells in the control group exhibited intact homogeneous blue and round nuclei (Fig. 2B) . Apoptotic/necrotic cells were not observed in cells treated with 9-HPbD or laser irradiation alone (data not shown).
9-HPbD-PDT initiates mitochondrial depolarization.
Cells were stained with rhodamine 123, and MMP in single cells was monitored using flow cytometry and confocal microscopy. A collapsed MMP, shown as a leftward shift of the fluorescence curve from flow cytometry, was observed in a 9-HPbD dose-dependent manner (Fig. 3A) . Polarized mitochondria were demonstrated by the presence of bright fluorescent spheres and tubes using confocal microscopy. A total of 2 h following PDT, the majority of the bright spheres became faint and rhodamine 123 fluorescence intensity was caliginous, indicating mitochondrial depolarization (Fig. 3B ).
9-HPbD-PDT suppressed the migration and EGFR expression in HN-3 cells.
A wound healing assay was used to evaluate the effect of 9-HPbD-PDT on the migration of HN-3 cells. As shown in Fig. 4 , PDT significantly suppressed the migration of HN-3 cells in a sensitizer dose-dependent manner. The migration distance of HN-3 cells decreased from 0.74±0.07 observed in the control group to 0.63±0.07 mm in the 0.29 µg/ml 9-HPbD-PDT group (P=0.007) and 0.13±0.05 mm in the 0.59 µg/ml 9-HPbD-PDT group (P=0.001) (Fig. 4) .
In contrast to the untreated group, there was clear inhibition of EGFR expression in PDT groups in a sensitizer dose-dependent manner (Fig. 5A) . Downregulation in the expression of EGFR was partially inhibited when the cells were pretreated with ascorbic acid (Fig. 5B) . As the native substrate of caspase-3, PARP was measured using western blotting. Similarly to EGFR expression, there was an elevated expression of PARP in a sensitizer dose-dependent manner (Fig. 5A) . When cells were pretreated with GSH and ascorbic acid, upregulation of PARP was significantly inhibited (Fig. 5B) .
Discussion
In the present study, phototoxicity was not observed when HN-3 cells were treated with 9-HPbD or laser irradiation alone. In the presence of a laser, 9-HPbD had significant photocytotoxicity and an induction of apoptosis and necrosis was observed, which was a photosensitizer dose-dependent response. These results demonstrate the basic rule of PDT: There is a synergistic effect between lasers and photosensitizers, which is required since laser nor photosensitizer alone is photocytotoxic (7) .
The basic principle of PDT is that rapid ROS generation, due to the photochemical activation of the photosensitizer, initiates cell death (8) . Consistent with increased ROS signals, in the present study there was gradually induction of apoptosis in HN-3 cells treated with 0.29-1.17 µg/ml 9-HPbD-PDT. In cells treated with higher doses of 9-HPbD-PDT (1.17-4.69 µg/ml), there was a gradual increase of necrotic cells with 9-HPbD concentration, whereas ROS signals were remarkably attenuated. This may be associated with nonspecific relocalization of photosensitizer targets at higher doses, including to lysosomes or the plasma membrane, which may either block or delay the apoptotic program, thus predisposing the cells to necrosis (9) . Apoptotic and necrotic cells were not observed when cells were treated with 9-HPbD or a laser alone (data not shown). These results suggest that 9-HPbD shares the same characteristics as other photosensitizers; photosensitizers minimize the undesirable effects of anti-tumor drugs towards normal tissue during treatment (2). This is one of the advantages of PDT over other conventional cancer treatment modalities, including surgery, radiation and chemotherapy. The advantage of selective tumor destruction with normal tissue preservation is of particular importance for cancers in the head and neck region, where excessive tissue loss results in significant functional disabilities including effects on speech and swallowing (2, 10) .
A positive regulatory function of PARP cleavage has been observed in the onset of apoptosis (11) . PARP, the native substrate of caspase-3 (12), was measured in the present study by western blotting, and this revealed that PARP was Although the involvement of multiple pathways during PDT-mediated cell death has been reported (1), the elucidation of the molecular mechanisms underlying PDT-mediated apoptosis and cell cycle deregulation is far from complete. An improved understanding of these pathways may lead to development of strategies for improving treatment protocols (4, 13, 14) , and therefore, increase the therapeutic efficacy of PDT.
Mitochondria are recognized as the most important cellular organelle for apoptosis inducement (15, 16) . Generally, 
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prior to cell death, a collapse of MMP is initiated. Collapsed MMP has been considered as an important factor that initiates the release of cytochrome c (17) . Following the release of mitochondrial cytochrome c into the cytosol, activation of the caspase cascade has been reported in PDT-induced apoptosis (18) . In the present study, a clear leftward shift of the fluorescence curve indicated a collapse of MMP in HN-3 cells treated with 9-HPbD-PDT, which occurred in a photosensitizer dose-dependent pattern. Similarly with increasing doses of 9-HPbD, mitochondrial morphology exhibited a gradual loss of characteristically bright spheres/tubes and more diffuse and weaker fluorescent signals were observed following PDT, due to leakage of the dye from the mitochondria into the cytosol. The disruption of MMP demonstrates the important role of mitochondria activation of apoptosis in HN-3 cells treated with 9-HPbD-PDT. An increased expression of EGFR has been reported in 90% of squamous cancer cells in the head and neck region (19) . It has been indicated that EGFR is important in tumor progression, in addition to its role in cellular proliferation (20) ; therefore, EGFR-inhibition has been recently considered as a candidate for the treatment of head and neck carcinoma (21, 22) . In the present study, there was a significant downregulation in the expression of EGFR in PDT groups in a photosensitizer dose-dependent manner compared with the high expression of EGFR observed in the control group, which may subsequently lead to migration suppression of HN-3 cancer cells, as observed in a previous experiment. This indicates that EGFR may be the target of 9-HPbD-PDT in HN-3 cells. EGFR also has a role in the activation of cell apoptosis and necrosis (23) . A downregulated expression of EGFR following PDT was partially inhibited by pretreatment with ascorbic acid, indicating a potential role of ROS in 9-HPbD-PDT-induced migration suppression.
Overall, 9-HPbD-PDT exhibits a phototoxic effect in HN-3 cells, as evidenced by an attenuated cell viability and activation of apoptosis and necrosis observed by the present study.
Mitochondrial activation under oxidative stress is important in 9-HPbD-PDT-induced apoptosis of HN-3 cells. The subcellular relocalization of 9-HPbD may lead to the distinguishing generation of ROS and subsequently determine the type of cell death. Migration suppression of HN-3 cells following PDT is partially due to the ROS-mediated inhibition of EGFR expression and/or phosphorylation (23) . However, the potential mechanisms involved in the photochemical effect of 9-HPbD-PDT on HN-3 cancer cells require further investigation. Figure 5 . 9-HPbD-PDT induced the cleavage of PARP (89 kDa), and inhibited the expression of EGFR (170 kDa). Laryngeal cancer AMC-HN-3 cells were treated with a sublethal dose of PDT, collected 24 h later, and subjected to western blot analysis. GAPDH (37 kDa) was used as a control. (A) Lane 1, control (no treatment); lane 2, 0.29 µg/ml 9-HPbD-PDT; lane 3, 0.59 µg/ml 9-HPbD-PDT. (B) Cells were treated with 0.59 µg/ml 9-HPbD-PDT alone or pretreated with 5 mM GSH or 2.5 mM ascorbic acid. GAPDH, glyceraldehyde 3-phosphate dehydrogenase; PARP, poly ADP-ribose polymerase; EGFR, epidermal growth factor receptor; 9-HpbD, 9-hydroxypheophorbide α; PDT, photodynamic therapy; GSH, glutathione.

